ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DRUG Bright Minds Biosciences Inc

54.23
-1.98 (-3.52%)
18 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bright Minds Biosciences Inc CSE:DRUG CSE Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.98 -3.52% 54.23 54.57 75.00 60.48 54.23 56.77 1,312 21:00:00

Dragon to Present at BioContact Quebec 2008

26/09/2008 12:00am

PR Newswire (US)


Bright Minds Biosciences (CSE:DRUG)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Bright Minds Biosciences Charts.
VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced that Ms. Maggie Deng, Chief Operating Officer and Mr. Garry Wong, Chief Financial Officer will present at 9:30 a.m. ET on Friday, October 3, 2008 at BioContact Quebec 2008 at the Chateau Frontenac hotel in Quebec City, Canada. Ms. Maggie Deng and Mr. Garry Wong will present Dragon Pharma's business overview including product lines, competitive strengths, and key growth strategies. BioContact Quebec 2008 is a biopharmaceutical partnership symposium that brings together over 1,200 participants from biopharmaceutical companies to present various sectors and disciplines of their companies. The conference will be held on October 1-3, for more information about the conference, please visit http://www.biocontact.qc.ca/english/default.html. About Dragon Pharmaceutical Inc. Dragon Pharmaceutical, headquartered in Vancouver, Canada, is a leading manufacturer and distributor of a broad line of high-quality antibiotic products including 7-ACA, a key intermediate to produce cephalosporin antibiotics, clavulanic acid, and formulated cephalosporin antibiotic drugs. Dragon is the third largest 7-ACA producer and the first manufacturer and market leader of clavulanic acid products in China. Dragon utilizes its nationwide sales distribution network, close customer relationships, understanding of local markets and customer needs and low cost structure to outperform its international and domestic peers. With an annual capacity of 780 tons, Dragon is the largest exporter of 7-ACA in China. To learn more about Dragon Pharmaceutical Inc., please visit http://www.dragonpharma.com/. DATASOURCE: Dragon Pharmaceutical Inc. CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, Chief Operating Officer or Karen Huang, Manager, Business Research & Development, Telephone: (604) 669-8817 or North America Toll Free: 1-877-388-3784, Email: , Website: http://www.dragonpharma.com/

Copyright

1 Year Bright Minds Biosciences Chart

1 Year Bright Minds Biosciences Chart

1 Month Bright Minds Biosciences Chart

1 Month Bright Minds Biosciences Chart

Your Recent History

Delayed Upgrade Clock